PDT Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Buy |
94,307
+56,926
| +152% | +$1.79M | 0.17% | 210 |
|
|
2025
Q1 | $1.22M | Sell |
37,381
-17,627
| -32% | -$577K | 0.09% | 357 |
|
|
2024
Q4 | $1.99M | Buy |
55,008
+17,898
| +48% | +$647K | 0.18% | 205 |
|
|
2024
Q3 | $1.16M | Buy |
+37,110
| New | +$1.16M | 0.1% | 331 |
|
|
2024
Q2 | – | Sell |
-49,030
| Closed | -$1.67M | – | 745 |
|
|
2024
Q1 | $1.67M | Buy |
+49,030
| New | +$1.67M | 0.16% | 227 |
|
|
2023
Q1 | – | Sell |
-44,646
| Closed | -$1.59M | – | 712 |
|
|
2022
Q4 | $1.59M | Buy |
44,646
+12
| +0% | +$428 | 0.26% | 132 |
|
|
2022
Q3 | $1.51M | Sell |
44,634
-21,309
| -32% | -$721K | 0.23% | 117 |
|
|
2022
Q2 | $1.91M | Buy |
+65,943
| New | +$1.91M | 0.17% | 185 |
|
|
2020
Q2 | – | Sell |
-28,550
| Closed | -$514K | – | 819 |
|
|
2020
Q1 | $514K | Buy |
28,550
+13,512
| +90% | +$243K | 0.04% | 363 |
|
|
2019
Q4 | $357K | Buy |
+15,038
| New | +$357K | 0.02% | 495 |
|
|
2016
Q3 | – | Sell |
-97,600
| Closed | -$1.99M | – | 511 |
|
|
2016
Q2 | $1.99M | Hold |
97,600
| – | – | 0.16% | 199 |
|
|
2016
Q1 | $1.49M | Sell |
97,600
-16,100
| -14% | -$245K | 0.09% | 267 |
|
|
2015
Q4 | $1.53M | Buy |
113,700
+16,100
| +16% | +$216K | 0.21% | 172 |
|
|
2015
Q3 | $1.37M | Sell |
97,600
-600
| -0.6% | -$8.42K | 0.03% | 609 |
|
|
2015
Q2 | $1.67M | Buy |
98,200
+50,659
| +107% | +$860K | 0.04% | 504 |
|
|
2015
Q1 | $575K | Buy |
+47,541
| New | +$575K | 0.01% | 961 |
|
|
2014
Q2 | – | Sell |
-21,539
| Closed | -$193K | – | 1620 |
|
|
2014
Q1 | $193K | Buy |
+21,539
| New | +$193K | ﹤0.01% | 1237 |
|